BioSpace News Archive

Lumenis recognized for exceptional innovative design of flagship surgical technology

Patient Support Program Launched with New Therapy Provides Sustainability Initiative, Donations for PI Charities and Educational Resources

As part of this update, the FDA is sharing a compilation of adverse event reports of DCM submitted to the agency through April 30, 2019, an updated case count, and new testing results.

BillionToOne, a venture-backed precision diagnostics company, today announced that the company’s first product, UNITY™, is now available for commercial and clinical use.

Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Adamas faced significant roadblocks that would drastically reduce its ability to sell Gocovro.

JOY Undiluted, the mental health and wellness hub, is ramping up their efforts to ‘raise the joy quotient’ of the world through their website, mobile app, and a directory of practitioners

Researchers have discovered a potential biomarker in the pupillary response of some pediatric patients with Bowel and Bladder Dysfunction (BBD) that could improve the speed and accuracy of diagnosis and treatment, according to a study from Children’s National Health System published in the Journal of Pediatric Urology.

Arlington Capital Partners (“Arlington”), a Washington, DC-based private equity firm, announced today it has completed a majority growth investment in Riverpoint Medical (“Riverpoint” or the “Company”).

Hartford HealthCare has named Jeffrey A. Flaks its President and Chief Executive Officer, effective September 1.

ArQule, Inc. announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,387,500 shares at the public offering price of $9.75 per share.